| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ACURA PHARMACEUTICALS, INC | Director | Common Stock | 675,989 | 02 Jan 2026 | Direct | ||
| ACURA PHARMACEUTICALS, INC | Director | Restricted Stock Units (2021 Plan) | 50,000 | 02 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000110465926004050-skelly-william-g-2026-01-02 | ACURA PHARMACEUTICALS, INC | 02 Jan 2026 | 3 | $0 | 4 | Director | 15 Jan 2026, 14:34 |
| /report/000110465925006021-skelly-william-g-2025-01-02 | ACURA PHARMACEUTICALS, INC | 02 Jan 2025 | 3 | $0 | 4 | Director | 24 Jan 2025, 16:45 |
| /report/000110465924000288-skelly-william-g-2024-01-02 | ACURA PHARMACEUTICALS, INC | 02 Jan 2024 | 3 | $0 | 4 | Director | 02 Jan 2024, 15:23 |
| /report/000110465923001399-skelly-william-g-2023-01-03 | ACURA PHARMACEUTICALS, INC | 03 Jan 2023 | 3 | $0 | 4 | Director | 05 Jan 2023, 15:05 |
| /report/000110465922001474-skelly-william-g-2022-01-03 | ACURA PHARMACEUTICALS, INC | 03 Jan 2022 | 3 | $0 | 4 | Director | 05 Jan 2022, 15:15 |
| /report/000110465921074154-skelly-william-g-2021-05-25 | ACURA PHARMACEUTICALS, INC | 25 May 2021 | 1 | $0 | 4 | Director | 28 May 2021, 16:11 |